US 12031136
Treatment for skeletal diseases caused by intracellular protein trafficking defects
granted A61KA61K31/155A61K31/16
Quick answer
US patent 12031136 (Treatment for skeletal diseases caused by intracellular protein trafficking defects) held by The Board of Regents of the University of Oklahoma expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/155, A61K31/16, A61K31/18, A61K31/19